Mechanisms of the role of proto-oncogene activation in promoting malignant transformation of mature B cells
View abstract on PubMed
Summary
This summary is machine-generated.Proto-oncogenes drive cell malignant transformation, particularly in B cells. Understanding these oncogenes and their mechanisms is crucial for developing new antitumor drugs and improving cancer treatment.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Malignant tumors are a major threat, driven by proto-oncogene activation and tumor suppressor gene inactivation.
- Proto-oncogene activation is a key driver of cellular malignant transformation.
- Oncogenes and their metabolites regulate B cell development and malignant transformation into tumors.
Purpose Of The Study
- To summarize key oncogenes involved in the malignant transformation of mature B cells.
- To elucidate the mechanisms of action of these oncogenes in tumor development.
- To highlight the significance for clinical antitumor drug development.
Main Methods
- Review of preclinical and clinical studies.
- Analysis of oncogene pathways in B cell development.
- Investigation of oncogene-driven tumor formation mechanisms.
Main Results
- Identification of critical oncogenes regulating mature B cell transformation.
- Elucidation of specific molecular mechanisms underlying oncogene-induced B cell tumorigenesis.
- Demonstration of the therapeutic potential of targeting these oncogenes.
Conclusions
- Targeting oncogenes offers a promising strategy for novel antitumor drug development.
- Understanding oncogene roles in B cell malignancies is vital for effective clinical treatments.
- Further research into oncogene pathways can lead to improved cancer therapies.
Related Concept Videos
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

